STAAR SURGICAL CO — Director's Dealing 2023

Jan 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2022-12-30

Reporting Person: Francese James E (Sr. VP, Comm. Ops., NA, APAC)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-30	Common Stock Options	$48.54	M	19139	Acquired	2032-12-29	Common Stock (19139)	Direct

Footnotes

F1: The options granted become exercisable as follows: 1/3 on 12/30/2023 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 12/30/2025.